SCHEMBL1799596

SCHEMBL1799596

Cc1sc(NC(=O)COCC(=O)NC(c2ccccc2)c2ccccc2)c(C(=O)OC(C)(C)C)c1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.45
HPGD P15428 3/20 0.45
LMNA P02545 7/20 0.45
HTT P42858 3/20 0.45
THRB P10828 3/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
KDM4E B2RXH2 2/20 0.44
GAA P10253 2/20 0.44
MAPT P10636 5/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
PTBP1 P26599 1/20 0.43
TSHR P16473 1/20 0.42
RECQL P46063 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
POLB P06746 1/20 0.40
MAPK1 P28482 1/20 0.40
ATM Q13315 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1795054 0.91 ALDH1A1 (0.53) ALDH1A1HPGDLMNAHTTTHRB
SCHEMBL1796876 0.88 ALDH1A1 (0.50) ALDH1A1HPGDLMNAHTTTHRB
SCHEMBL1797214 0.88 ALDH1A1 (0.50) ALDH1A1HPGDLMNAHTTTHRB
SCHEMBL1796249 0.88 ALDH1A1 (0.53) ALDH1A1HPGDLMNAHTTTHRB
SCHEMBL1795271 0.82 SERPINE1 (0.50) ALDH1A1HPGDLMNAHTTTHRB
SCHEMBL1797940 0.80 ALDH1A1 (0.45) ALDH1A1HPGDLMNAHTTTHRB
SCHEMBL1802068 0.79 SERPINE1 (0.45) ALDH1A1HPGDLMNAHTTTHRB
SCHEMBL1798224 0.79 KDM4E (0.42) ALDH1A1HPGDLMNAHTTTHRB
SCHEMBL1798768 0.79 ALDH1A1 (0.42) ALDH1A1HPGDLMNAHTTTHRB
SCHEMBL1797219 0.78 ALDH1A1 (0.59) ALDH1A1HPGDLMNAHTTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 ALDH1A1 800/4885HPGD 920/4885LMNA 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.